HIGHLIGHTS
- who: August et al. from the Guilin Medical University, China have published the article: Recent advances on development of p21-activated kinase 4 inhibitors as anti-tumor agents, in the Journal: (JOURNAL)
SUMMARY
Accumulating evidence have disclosed that PAKs are cross-linked with multiple signaling pathways, including WNT, ErbB2, MAPK, and many others (Radu et_al, 2014; Kumar et_al, 2017). PAKs also play crucial roles in cytoskeleton remodeling, cell adhesion, mitosis, neural differentiation, and cardiomyogenesis (Kelly and Chernoff, 2012; Kuzelova et_al, 2021; Zhang et_al, 2022). The structure, the function and the expression of p21 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.